Prion infection modulates hematopoietic stem/progenitor cell fate through cell-autonomous and non-autonomous mechanisms.
Hyun-Jaung SimYong-Chan KimGovinda BhattaraiSae-Young WonJeong-Chae LeeByung-Hoon JeongSung-Ho KookPublished in: Leukemia (2023)
Studies of PrP C -derived prion disease generally focus on neurodegeneration. However, little is known regarding the modulation of hematopoietic stem progenitor cells (HSPCs) that express PrP C in prion infection. Among bone marrow (BM) hematopoietic cells, hematopoietic stem cells (HSCs) strongly express PrP C . A bioassay revealed the presence of misfolded prion protein (PrP Sc ) in BM cells derived from prion-infected mice; these BM cells demonstrated reproducible prion infectivity. At 5 months after infection with ME7, mice exhibited a significant decrease in the number of HSPCs. This decrease was mainly driven by increased apoptotic cell death, rather than cell cycle progression and senescence, in PrP C -positive but not PrP C -negative HSPC populations through a cell-autonomous mechanism. Notably, both PrP C -positive and PrP C -negative HSCs underwent cellular senescence, as indicated by high levels of senescence-associated factors and deficits in repopulation and self-renewal capacities at 7 months after infection. Senescence of HSCs occurred in the ME7-impaired BM microenvironment with aging phenotypes through non-cell autonomous mechanisms. These data provide novel evidence that prion infection differentially modulates HSC fate through both cell-autonomous and non-autonomous mechanisms.
Keyphrases
- platelet rich plasma
- cell death
- bone marrow
- cell cycle arrest
- single cell
- stem cells
- cell cycle
- induced apoptosis
- cell therapy
- dna damage
- endothelial cells
- cell proliferation
- mesenchymal stem cells
- traumatic brain injury
- stress induced
- adipose tissue
- machine learning
- anti inflammatory
- binding protein
- deep learning
- wild type